Hu Han

695 total citations
16 papers, 469 citations indexed

About

Hu Han is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Hu Han has authored 16 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Infectious Diseases. Recurrent topics in Hu Han's work include Gut microbiota and health (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Hu Han is often cited by papers focused on Gut microbiota and health (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Hu Han collaborates with scholars based in China, Egypt and Japan. Hu Han's co-authors include Yan Tan, Rong Jin, Quan Zhang, Zhi Peng, Jian Li, Yan Kou, Xiaotian Zhang, Ziqi Wang, Xianglin Yuan and Siyuan Cheng and has published in prestigious journals such as The Science of The Total Environment, Frontiers in Immunology and Frontiers in Pharmacology.

In The Last Decade

Hu Han

13 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hu Han China 8 297 272 74 68 61 16 469
Tomoki Saito Japan 6 272 0.9× 202 0.7× 50 0.7× 37 0.5× 56 0.9× 18 409
Cheng‐Bei Zhou China 9 329 1.1× 164 0.6× 86 1.2× 36 0.5× 81 1.3× 12 479
Safae Terrisse France 7 245 0.8× 268 1.0× 96 1.3× 47 0.7× 45 0.7× 18 424
Zoe X. Malchiodi United States 6 238 0.8× 256 0.9× 25 0.3× 90 1.3× 74 1.2× 11 381
Wenhua You China 7 239 0.8× 144 0.5× 51 0.7× 56 0.8× 117 1.9× 12 442
Manning Qian China 7 234 0.8× 123 0.5× 44 0.6× 38 0.6× 61 1.0× 11 387
Vrishketan Sethi United States 10 388 1.3× 416 1.5× 47 0.6× 170 2.5× 140 2.3× 27 686
Judith Garriga United States 4 335 1.1× 184 0.7× 42 0.6× 72 1.1× 22 0.4× 4 454
Zhujiang Dai China 8 248 0.8× 112 0.4× 45 0.6× 37 0.5× 34 0.6× 19 361

Countries citing papers authored by Hu Han

Since Specialization
Citations

This map shows the geographic impact of Hu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Han more than expected).

Fields of papers citing papers by Hu Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Han. The network helps show where Hu Han may publish in the future.

Co-authorship network of co-authors of Hu Han

This figure shows the co-authorship network connecting the top 25 collaborators of Hu Han. A scholar is included among the top collaborators of Hu Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hu Han. Hu Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Moehler, Markus, Harry H. Yoon, Daniel‐Christoph Wagner, et al.. (2025). Concordance Between the PD-L1 Tumor Area Positivity Score and Combined Positive Score for Gastric or Esophageal Cancers Treated With Tislelizumab. Modern Pathology. 38(9). 100793–100793. 4 indexed citations
2.
Han, Hu, Akbar Ali, Khalid J. Alzahrani, et al.. (2025). Pharmacotherapeutic role of astringin against chromium induced nephrotoxicity via modulating TLR4/MyD88, HMGB1/RAGE and NF-κB pathway: A biochemical and pharmacokinetic approach. Journal of Trace Elements in Medicine and Biology. 89. 127666–127666. 2 indexed citations
3.
Yang, Yang, et al.. (2025). Epidemiological Characteristics of Foodborne Disease Outbreaks in a Hospital: A 5-Year Retrospective Study. International Journal of General Medicine. Volume 18. 1529–1542.
4.
Han, Hu, et al.. (2025). Analysis of Risk Factors for Severe Pneumonia Progression in Chlamydia psittaci Infections: A Retrospective Study. International Journal of General Medicine. Volume 18. 5605–5615.
5.
Zhang, Qian, Yating Li, Hu Han, et al.. (2024). Serum arsenic augments gallstone risk in Henan rural cohort with multiple metal exposure. The Science of The Total Environment. 952. 175991–175991.
6.
Han, Hu, Yan Li, Lu Wang, et al.. (2022). miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling. Cancer Cell International. 22(1). 42–42. 16 indexed citations
7.
Yu, Qianqian, Long Li, Bili Wu, et al.. (2022). Kinsenoside Protects Against Radiation-Induced Liver Fibrosis via Downregulating Connective Tissue Growth Factor Through TGF-β1 Signaling. Frontiers in Pharmacology. 13. 808576–808576. 14 indexed citations
8.
Huang, Yu, Ning Zhu, Zheng Xing, et al.. (2022). Intratumor Microbiome Analysis Identifies Positive Association Between Megasphaera and Survival of Chinese Patients With Pancreatic Ductal Adenocarcinomas. Frontiers in Immunology. 13. 785422–785422. 59 indexed citations
9.
Yin, Han, Lu Wang, Beibei Su, et al.. (2022). Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota. Aging. 14(4). 1941–1958. 80 indexed citations
10.
Zhou, Youlian, Yan He, Le Liu, et al.. (2021). Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases. Frontiers in Nutrition. 8. 615064–615064. 12 indexed citations
11.
Peng, Zhi, Siyuan Cheng, Yan Kou, et al.. (2020). The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer. Cancer Immunology Research. 8(10). 1251–1261. 235 indexed citations
12.
Yuan, Ye, Hu Han, Yu Jin, et al.. (2020). Implications of the autophagy core gene variations on brain metastasis risk in non-small cell lung cancer treated with EGFR-TKI*. Oncology and Translational Medicine. 6(5). 185–192. 1 indexed citations
13.
Wan, Qin, Jun Zou, Yongbiao Huang, et al.. (2020). Pirfenidone facilitates immune infiltration and enhances the antitumor efficacy of PD-L1 blockade in mice. OncoImmunology. 9(1). 1824631–1824631. 28 indexed citations
14.
Jin, Yu, et al.. (2019). Phosphorylated-Akt overexpression is associated with a higher risk of brain metastasis in patients with non-small cell lung cancer. Biochemistry and Biophysics Reports. 18. 100625–100625. 12 indexed citations
15.
16.
Li, Jingjing, et al.. (2011). [Genome cloning of human bocavirus (HBoV1) and analysis of viral promoter activity].. PubMed. 27(6). 909–16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026